Atlas FDA

Orsiro Mission Sirolimus Eluting Coronary Stent System

FDA premarket approval P170030/S056 · decided 2025-10-10

Approval details

PMA number
P170030
Supplement
S056
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Orsiro Mission Sirolimus Eluting Coronary Stent System
Generic name
Coronary drug-eluting stent
Applicant
Biotronik AG
Date received
2025-06-05
Decision date
2025-10-10
Days to decision
127 days
Decision code
APPR
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Bülach
Statement
approval for an alternative manufacturing site for the coating process of a catheter component

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PHERON PERIPHERAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER (K052757)Biotronik AG2005-10-28